Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.

Similarly, in a sensitivity analysis restricted to patients with biopsy proven KS only, patients with three or more chemotherapy indications had a 2.12 (95% CI 0.93–4.86, Model 1) times risk of rapid chemotherapy initiation, though this did not quite reach statistical significance due to the smaller sample size of patients that had biopsy-proven disease ( p = 0.07).

also in 679 other papers